CS244681B2 - Preparation method of 2,6-piperidin-dione-derivatives - Google Patents

Preparation method of 2,6-piperidin-dione-derivatives Download PDF

Info

Publication number
CS244681B2
CS244681B2 CS838220A CS822083A CS244681B2 CS 244681 B2 CS244681 B2 CS 244681B2 CS 838220 A CS838220 A CS 838220A CS 822083 A CS822083 A CS 822083A CS 244681 B2 CS244681 B2 CS 244681B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
mixture
product
alkyl
piperidinedione
Prior art date
Application number
CS838220A
Other languages
Czech (cs)
English (en)
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Priority to CS845728A priority Critical patent/CS244694B2/cs
Publication of CS244681B2 publication Critical patent/CS244681B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS838220A 1982-11-08 1983-11-08 Preparation method of 2,6-piperidin-dione-derivatives CS244681B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS845728A CS244694B2 (cs) 1982-11-08 1984-07-25 Způsob výroby derivátů 2,6-piperidindionu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (1)

Publication Number Publication Date
CS244681B2 true CS244681B2 (en) 1986-08-14

Family

ID=9279000

Family Applications (1)

Application Number Title Priority Date Filing Date
CS838220A CS244681B2 (en) 1982-11-08 1983-11-08 Preparation method of 2,6-piperidin-dione-derivatives

Country Status (29)

Country Link
US (1) US4721710A (de)
EP (1) EP0110755B1 (de)
JP (1) JPS59161377A (de)
KR (1) KR900006721B1 (de)
AT (1) ATE22561T1 (de)
AU (1) AU565519B2 (de)
CA (1) CA1221967A (de)
CS (1) CS244681B2 (de)
DD (3) DD229407A5 (de)
DE (1) DE3366623D1 (de)
DK (1) DK511383A (de)
ES (1) ES527091A0 (de)
FI (1) FI79536C (de)
FR (1) FR2535721A1 (de)
GR (1) GR78747B (de)
HU (1) HU191494B (de)
IE (1) IE56209B1 (de)
IL (1) IL70099A (de)
MA (1) MA19948A1 (de)
NO (1) NO159852C (de)
NZ (1) NZ206177A (de)
OA (1) OA07582A (de)
PH (1) PH20421A (de)
PL (3) PL139946B1 (de)
PT (1) PT77607B (de)
SG (1) SG1989G (de)
SU (3) SU1333237A3 (de)
YU (3) YU221183A (de)
ZA (1) ZA838065B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
AU2012255860C1 (en) 2011-05-17 2015-12-10 Principia Biopharma Inc. Tyrosine kinase inhibitors
WO2012158795A1 (en) 2011-05-17 2012-11-22 Principia Biopharma Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
DK2710007T3 (da) 2011-05-17 2020-01-27 Principia Biopharma Inc Kinasehæmmere
EP2892900B1 (de) 2012-09-10 2017-08-16 Principia Biopharma Inc. Pyrazolopyrimidin-verbindungen als kinase-inhibitoren
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
SG11201606858RA (en) 2014-02-21 2016-09-29 Principia Biopharma Inc Salts and solid form of a btk inhibitor
ES2843323T3 (es) 2014-12-18 2021-07-16 Principia Biopharma Inc Tratamiento de pénfigo
TW201718572A (zh) 2015-06-24 2017-06-01 普林斯匹亞生物製藥公司 酪胺酸激酶抑制劑
IL263815B (en) 2016-06-29 2022-07-01 Principia Biopharma Inc Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(Oxtan-3-yl)piperazin-1-yl)pent-2-ananitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
DE3366623D1 (en) 1986-11-06
PT77607A (fr) 1983-12-01
IL70099A (en) 1987-10-20
EP0110755B1 (de) 1986-10-01
PL249750A1 (en) 1985-03-12
SU1333237A3 (ru) 1987-08-23
YU184185A (en) 1986-06-30
ES8406070A1 (es) 1984-07-01
DD229407A5 (de) 1985-11-06
IE832581L (en) 1984-05-08
OA07582A (fr) 1985-03-31
NZ206177A (en) 1985-11-08
CA1221967A (en) 1987-05-19
KR840006641A (ko) 1984-12-01
ES527091A0 (es) 1984-07-01
NO159852B (no) 1988-11-07
IE56209B1 (en) 1991-05-22
PT77607B (fr) 1986-03-18
IL70099A0 (en) 1984-01-31
PH20421A (en) 1987-01-05
SU1333238A3 (ru) 1987-08-23
FI79536C (fi) 1990-01-10
GR78747B (de) 1984-10-02
PL244462A1 (en) 1985-02-13
NO834057L (no) 1984-05-09
FI79536B (fi) 1989-09-29
NO159852C (no) 1989-02-15
DK511383D0 (da) 1983-11-08
YU184285A (en) 1986-06-30
ATE22561T1 (de) 1986-10-15
FR2535721B1 (de) 1985-05-17
PL140992B1 (en) 1987-06-30
US4721710A (en) 1988-01-26
SU1316558A3 (ru) 1987-06-07
DD229402A5 (de) 1985-11-06
EP0110755A1 (de) 1984-06-13
KR900006721B1 (ko) 1990-09-20
MA19948A1 (fr) 1984-07-01
DD219770A5 (de) 1985-03-13
FR2535721A1 (fr) 1984-05-11
FI834087A (fi) 1984-05-09
PL249749A1 (en) 1985-03-12
JPS59161377A (ja) 1984-09-12
YU221183A (en) 1986-06-30
PL140021B1 (en) 1987-03-31
HU191494B (en) 1987-02-27
FI834087A0 (fi) 1983-11-08
AU2089883A (en) 1984-05-17
ZA838065B (en) 1984-06-27
PL139946B1 (en) 1987-03-31
DK511383A (da) 1984-05-09
AU565519B2 (en) 1987-09-17
SG1989G (en) 1989-06-02

Similar Documents

Publication Publication Date Title
US5338849A (en) Azaindoles, preparation processes and medicinal products containing them
US5786481A (en) N-alkyl and N-acyl derivatives of 3,7-Diazabicyclo- 3.3.1!nonanes and selected salts thereof as multi-class antiarrhythmic agents
CS244681B2 (en) Preparation method of 2,6-piperidin-dione-derivatives
EP0025111A1 (de) 3-Aminopropoxyaryl-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
JPS62198666A (ja) 1−ベンジル−2−/n−置換/−カルバモイル−テトラヒドロイソキノリン及びその製造方法
GB1568398A (en) Triazolo pyridazine derivatives
US3966760A (en) 2-Substituted-5,6-dimethoxyindazoles
Fisher et al. Quinoxaline studies. XXII. Tosylation and chiralities of 2-substituted 1, 2, 3, 4-tetrahydroquinoxalines
KR870001681B1 (ko) 히단토인 유도체의 제조방법
EP0670837A1 (de) NEUES VERFAHREN ZUR HERSTELLUNG VON -g(b)-CARBOLINEN.
US4105774A (en) Hydantoin compounds and methods of use thereof
JPH03181473A (ja) 複素環式化合物、その製造方法、これを含有する心臓血管障害の治療用の医薬およびその製造のための中間体
DE69818988T2 (de) 9,10-diazatryclo[4.2.11 2,5]decan- und 9,10-diazatricyclo[3.3.1.1 2,6]decanderive mit analgetischer wirkung
DE2526966A1 (de) Tricyclische alkylaminverbindungen, verfahren zu ihrer herstellung und sie enthaltende mittel
US2897195A (en) Nxyxc
US4983603A (en) Tricyclic cholinergic receptor agonists
CH630902A5 (en) Process for preparing novel derivatives of 1,2,3,4,4a,10b-hexahydrobenzo(f)isoquinoline.
Corral et al. N-Substituted 2-amino-1-(2-thienyl) ethanols as. beta.-adrenergic blocking agents
DE1620342C3 (de)
US6008352A (en) 1-(isoquinolin-1-yl)-4-(1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands
EP0014996B1 (de) Heterocyclische spiroverknüpfte Amidine, ihre Stereoisomeren und optischen Isomeren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CS244695B2 (cs) Způsob přípravy derivátů 2,6-piperidíndionu
CS244680B2 (en) Preparation method of gama butyrolactone
US3377380A (en) Dibenzocycloheptenyl carboxyhydrazides
NL7908030A (nl) Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.